Literature DB >> 30199748

A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies.

Oscar Ekpenyong1, Candace Cooper1, Jing Ma1, Dong Liang1, Omonike Olaleye1, Huan Xie2.   

Abstract

CLBQ14 is an 8-hydroxyquinoline analogue that inhibits methionine aminopeptidase (MetAP), an enzyme responsible for the post-translational modification of several proteins and polypeptides. MetAP has been validated as druggable target for some infectious diseases, and its inhibitors have been investigated as potential therapeutic agents. In this study, we developed and validated a liquid chromatography tandem-mass spectrometry (LC-MS/MS) method for the quantification of CLBQ14 in solution, and in rat plasma and urine. This method was applied to the pharmacokinetic evaluation of CLBQ14 in adult male Sprague Dawley (SD) rats. Chromatographic separation was achieved using an ultra-high-performance liquid chromatography (UHPLC) system equipped with Waters XTerra MS C18 column (3.5 μm, 125 Å, 2.1 × 50 mm) using 0.1% formic acid in acetonitrile/water gradient system as mobile phase. Chromatographic analysis was performed with a 4000 QTRAP® mass spectrometer using MRM in positive mode for CLBQ14 transition [M + H]+m/z 257.919 → m/z 151.005, and IS (clioquinol) transition [M + H]+m/z 305.783 → m/z 178.917. CLBQ14 was extracted from plasma and urine samples by protein precipitation. The retention times for CLBQ14 and IS were 1.31 and 1.40 min respectively. The standard curves were linear for CLBQ14 concentration ranging from 1 to 1000 ng/mL. The intra-day and inter-day accuracy and precision were found to be within 15% of the nominal concentration. Extraction recoveries were >96.3% and 96.6% from rat plasma and urine respectively, and there was no significant matrix effect from the biological matrices. CLBQ14 is stable in samples subjected to expected storage, preparation, and handling conditions. Pharmacokinetic studies revealed that CLBQ14 has a bi-exponential disposition in SD rats, is extensively distributed with a long plasma half-life and is eliminated primarily by liver metabolism.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  8-Hydroxyquinoline; Bio-analytical method development; LC-MS/MS; Pharmacokinetics

Mesh:

Substances:

Year:  2018        PMID: 30199748      PMCID: PMC6163080          DOI: 10.1016/j.jchromb.2018.08.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  22 in total

1.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

2.  Methionine aminopeptidase-1: the MAP of the mitochondrion?

Authors:  P J Keeling; W F Doolittle
Journal:  Trends Biochem Sci       Date:  1996-08       Impact factor: 13.807

3.  Growth inhibition of Escherichia coli and methicillin-resistant Staphylococcus aureus by targeting cellular methionine aminopeptidase.

Authors:  Sergio C Chai; Wen-Long Wang; De-Rong Ding; Qi-Zhuang Ye
Journal:  Eur J Med Chem       Date:  2011-05-05       Impact factor: 6.514

4.  Characterization of the biochemical properties of two methionine aminopeptidases of Cryptosporidium parvum.

Authors:  Jung-Mi Kang; Hye-Lim Ju; Woon-Mook Sohn; Byoung-Kuk Na
Journal:  Parasitol Int       Date:  2012-05-18       Impact factor: 2.230

5.  Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets.

Authors:  Omonike Olaleye; Tirumalai R Raghunand; Shridhar Bhat; Jian He; Sandeep Tyagi; Gyanu Lamichhane; Peihua Gu; Jiangbing Zhou; Ying Zhang; Jacques Grosset; William R Bishai; Jun O Liu
Journal:  Chem Biol       Date:  2010-01-29

6.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

7.  Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.

Authors:  Xiaochun Chen; Curtis R Chong; Lirong Shi; Tadashi Yoshimoto; David J Sullivan; Jun O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

8.  Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes.

Authors:  S M Arfin; R L Kendall; L Hall; L H Weaver; A E Stewart; B W Matthews; R A Bradshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Expression and characterization of two functional methionine aminopeptidases from Mycobacterium tuberculosis H37Rv.

Authors:  Xuelian Zhang; Shudan Chen; Zhidong Hu; Lu Zhang; Honghai Wang
Journal:  Curr Microbiol       Date:  2009-08-18       Impact factor: 2.188

10.  Control of protein life-span by N-terminal methionine excision.

Authors:  Carmela Giglione; Olivier Vallon; Thierry Meinnel
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

View more
  2 in total

1.  Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid.

Authors:  Xiuqing Gao; Lei Wu; Robert Y L Tsai; Jing Ma; Xiaohua Liu; Diana S-L Chow; Dong Liang; Huan Xie
Journal:  Pharmaceutics       Date:  2021-04-17       Impact factor: 6.321

2.  Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases.

Authors:  Oscar Ekpenyong; Xiuqing Gao; Jing Ma; Candace Cooper; Linh Nguyen; Omonike A Olaleye; Dong Liang; Huan Xie
Journal:  Drug Des Devel Ther       Date:  2020-03-30       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.